`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED
`
`Petitioner
`
`NOVARTIS PHARMACEUTICALS CORPORATION
`
`Patent Owner
`
`US. PATENT No. 8,410,131
`
`POWER OF ATTORNEY FOR WEST-WARD
`
`PHARMACEUTICALS INTERNATIONAL LIMITED
`
`Mail Stop PATENT BOARD
`Patent Trial and Appeal Board
`United States Patent and Trademark Office
`
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`
`
`West-Ward Pharmaceuticals International Limited hereby appoints the
`
`following practitioners associated with Goodwin Procter LLP as its attorneys to
`
`transact all business in the United States Patent and Trademark Office associated
`
`with the above-captioned inter partes review.
`
`
`
`
` BACK-UP COUNSEL
`
`LEAD COUNSEL
`Keith A. Zullow (Reg. No. 37,975)
`Marta E. Delsignore (Reg. No. 32,689)
`kzullow@goodwinprocter.com
`mdelsignore@goodwinprocter.com
`Goodwin Procter LLP
`Goodwin Procter LLP
`The New York Times Building
`The New York Times Building
`620 Eighth Avenue
`620 Eighth Avenue
`New York, NY 10018-1405
`New York, NY 10018-1405
`T: 212-813-8846; F: 646-558-4226
`T: 212-813-8822; F: 646-558-4079
`
`
`
`
`
`
`The individual(s) signing below has authority to execute this document on
`
`behalf of Petitioner West—Ward Pharmaceuticals International Limited.
`
`By. MES x "
`
`
`
`Title: SC V?&F?l Clmfn M49 gawk Optrcdfilx/LC
`
`Date:
`
`I lpSLn 42‘? l 9’
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that this “POWER OF ATTORNEY FOR
`
`WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED” was
`
`served in its entirety on this 17th day of January 2018 by FedEx First Overnight on
`
`Patent Owner and counsel of record for Novartis in Breckenridge Pharmaceutical,
`
`Inc. v. Novartis Pharmaceutical Corporation, IPR2017-01592 at their
`
`correspondence addresses as follows:
`
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`Attn: Peter J. Waibel, Esq. (Head of Patent Litigation)
`One Health Plaza 433/2
`East Hanover, NJ 07936-1080
`
`Novartis Pharmaceutical Corporation
`Intellectual Property Department
`Attn: Thomas Savitsky, Esq.
`One Health Plaza 433/2
`East Hanover, NJ 07936-1080
`
`Nicholas Kallas
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104-3800
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`In addition, Novartis AG was served via FedEx International Priority at the
`
`following address:
`
`Novartis International AG
`Novartis Campus
`Attn: Alisa A. Harbin, Esq.
`Head, Group Litigation and Intellectual property
`Forum 1-1.20
`Basel, CH-4002
`Switzerland
`
`Courtesy copies of the foregoing were also served by FedEx First
`
`
`
`Overnight to counsel of record for the Petitioner in Breckenridge Pharmaceutical,
`
`Inc. v. Novartis Pharmaceutical Corporation, IPR2017-01592 as follows:
`
`Breckenridge Pharmaceutical, Inc.
`
`
`
`Daniel R. Evans, Esq.
`MERCHANT & GOULD P.C.
`191 Peachtree Street, NE
`Suite 3800
`Atlanta, GA 30303
`
`
`
`
`
`January 17, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
` /Keith A. Zullow/
`Keith A. Zullow (Reg. No. 37,975)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`Tel: 212-813-8846
`Fax: 646-558-4226
`kzullow@goodwinprocter.com
`
`Counsel for Petitioner West-Ward
`Pharmaceuticals International Limited
`
`